Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT03715933
What this trial is testing

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Who this might be right for
Ewing SarcomaColorectal Adenocarcinoma
Inhibrx Biosciences, Inc 411
Early research (Phase 1)Study completedNCT01916135
What this trial is testing

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Who this might be right for
CarcinomaSarcomaMyeloma+2 more
Memorial Sloan Kettering Cancer Center 11
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT01389050
What this trial is testing

High Precision RT For Soft-Tissue Sarcoma

Who this might be right for
Soft-Tissue Sarcoma
University Health Network, Toronto 26
Testing effectiveness (Phase 2)Study completedNCT00002189
What this trial is testing

Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals

Who this might be right for
Sarcoma, KaposiHIV Infections
Baker Norton Pharmaceuticals
Not applicableLooking for participantsNCT07112989
What this trial is testing

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

Who this might be right for
Bone and Soft Tissue TumorsBone Metastases From Solid TumorsLung Metastases
Istituto Ortopedico Rizzoli 125
Not applicableStudy completedNCT01034696
What this trial is testing

Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting

Who this might be right for
SarcomaMelanoma
Royal Marsden NHS Foundation Trust 250
Not applicableUnknownNCT02309242
What this trial is testing

Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study

Who this might be right for
Sarcoma, Soft TissueOsteosarcoma Tumor
Universitaire Ziekenhuizen KU Leuven 60
Early research (Phase 1)WithdrawnNCT01236586
What this trial is testing

RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
LymphomaBrain NeoplasmsSarcoma+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04785196
What this trial is testing

APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors

Who this might be right for
LiposarcomaAdvanced Solid Tumor
Ascentage Pharma Group Inc. 95
Testing effectiveness (Phase 2)UnknownNCT01898962
What this trial is testing

Definitive Therapy for Oligometastatic Solid Malignancies

Who this might be right for
Stage IV or Recurrent Carcinoma or Sarcoma
Rocky Mountain Cancer Centers 110
Not applicableStudy completedNCT00026793
What this trial is testing

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Who this might be right for
Kaposi's Sarcoma
National Cancer Institute (NCI) 29
Not applicableStudy completedNCT01949506
What this trial is testing

(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas

Who this might be right for
Stage IV Adult Soft Tissue SarcomaSarcoma,Soft Tissue
Medical College of Wisconsin 9
Not applicableStudy completedNCT02996747
What this trial is testing

Low Grade Chondrosarcoma Versus Enchondroma

Who this might be right for
ChondromaChondrosarcoma
Istituto Ortopedico Rizzoli 102
Testing effectiveness (Phase 2)Study completedNCT03233204
What this trial is testing

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more
National Cancer Institute (NCI) 6
Not applicableUnknownNCT05272358
What this trial is testing

Economic Evaluation of Sarcoma Patients Management in France

Who this might be right for
Sarcoma
Centre Leon Berard 2,431
Early research (Phase 1)Study completedNCT01588678
What this trial is testing

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid TumorLymphoma
Daiichi Sankyo 32
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)Study completedNCT00238433
What this trial is testing

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 37
Testing effectiveness (Phase 2)UnknownNCT00021385
What this trial is testing

Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jonsson Comprehensive Cancer Center
Next Page